Výsledky vyhledávání

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

Autor: Nienke J de Boer-Veger, Roos van Westrhenen, Bianca Soree, Anne-Marie Buunk, Marga Nijenhuis, Hans Mulder, Henk-Jan Guchelaar, Vera H.M. Deneer, Gerard A. Rongen, Jesse J. Swen, Bob Wilffert, Jurriaan M. J. L. Brouwer, Ron H.N. van Schaik, Jan van der Weide, Elisa J. F. Houwink

Publikováno v: European Journal of Human Genetics, 30, 10, pp. 1114-1120
European Journal of Human Genetics, 30, 1114-1120
European journal of human genetics : EJHG
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30. Nature Publishing Group
European Journal of Human Genetics, 30, 1114-1120. Nature Publishing Group
European Journal of Human Genetics, 30(10). Nature Publishing Group

Contains fulltext : 286842.pdf (Publisher’s version ) (Closed access) The Dutch Pharmacogenetics Working Group (DPWG) guideline presented here, presents the gene-drug interaction between the genes CYP2C19 and CYP2D6 and antidepressants of the selec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565c0a685f5e344ceb85fd0fd0e5746c
https://hdl.handle.net/1887/3247348

Zobrazit plný text záznamu

Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients

Autor: Paola E. J. van der Meijden, Yvonne M. C. Henskens, Jurriën M Ten Berg, Leo Veenstra, Renske H. Olie, Minka J A Vries, Rachelle R K Hensgens, Hugo ten Cate, Otto Bekers, Petal A. Wijnen, Bianca T. A. de Greef

Publikováno v: Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 3992, p 3992 (2021)
Journal of Clinical Medicine, 10(17):3992. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 10
Issue 17

On-treatment platelet reactivity in clopidogrel-treated patients can be measured with several platelet function tests (PFTs). However, the agreement between different PFTs is only slight to moderate. Polymorphisms of the CYP2C19 gene have an impact o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a769db40ce575412681532250c7fc53c
https://pubmed.ncbi.nlm.nih.gov/34501440

Zobrazit plný text záznamu

Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype A POPular Genetics Subanalysis

Autor: Vera H.M. Deneer, Renicus S Hermanides, Carmine Morisco, Richard M. Tjon Joe Gin, Gerrit J.A. Vos, Arend Mosterd, Pim van der Harst, Daniel M.F. Claassens, Jean-Paul R. Herrman, Johannes C. Kelder, Willem Dewilde, Paul W.A. Janssen, Bakhtawar K. Mahmoodi, Arnoud W J van 't Hof, Jurriën M. ten Berg, Folkert W. Asselbergs, Thomas O. Bergmeijer, Emanuele Barbato

Publikováno v: Circulation-Cardiovascular interventions, 14(4):009434, 402-411. LIPPINCOTT WILLIAMS & WILKINS
Circulation. Cardiovascular interventions, 14(4). Lippincott Williams and Wilkins
Circulation: Cardiovascular Interventions, 14(4), 402. Lippincott Williams and Wilkins Ltd.
Circulation-Cardiovascular Interventions, 14(4):009434, 402-411. LIPPINCOTT WILLIAMS & WILKINS

Background: Guidelines favor ticagrelor or prasugrel over clopidogrel in patients with myocardial infarction. However, the POPular Genetics trial (Patient Outcome After Primary Percutaneous Coronary Intervention [PCI]) showed that in patients with pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54ef6016a26fcea7ac724e7cf6c3723
https://research.rug.nl/en/publications/c88d7bed-0522-46be-abfa-3331f07b3fe4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání